Printer Friendly

Albert Einstein College of Medicine of Yeshiva University obtains United States patent.

Albert Einstein College of Medicine of Yeshiva University (Bronx, NY) has patented methods of using of the sizes and levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, the -641 allele of the promoter of the gene encoding apolipoprotein C-3 (APOC-3), the 405 allele of the gene encoding cholesteryl ester transfer protein (CETP), and plasma levels of insulin-like growth factor-1 (IGF-1), adiponectin, CETP and APOC-3, for determining and increasing an individual's likelihood of longevity and of retaining cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease. (US 7,491,543)
COPYRIGHT 2009 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Feb 1, 2009
Words:102
Previous Article:The Open University obtains United States patent.
Next Article:Winner Medical Receives European Patent Office Approval for PurCotton Production Method.
Topics:


Related Articles
Einstein to honor Handlers.
Three execs lead Einstein golf and tennis tournament.
Industry execs lead Einstein tournament.
Albert Einstein College of Medicine obtains United States patent.
Yeshiva honors outstanding philanthropists.
Jonathan Mechanic to be honored by Men's Division of college.
Albert Einstein College of Medicine of Yeshiva University obtains United States patent.
Albert Einstein College of Medicine of Yeshiva University officially opened its 223,000 s/f Michael F. Price Center for Genetic and Translational...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |